| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |